The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.
Receiving ongoing, out-patient care at the University of Chicago Medical Center under the routine care of a physician participating in this trial
Life expectancy of at least 3 years
Must be 18 years or older
Must be taking at least 1 (but not more than 6) prescription medications at the time of enrollment OR be 65 years or older OR be reasonably expected to require the use of a prescription medication within the next 5 years
Patients with acute or chronic disease which could be reasonably expected to result in the patient's death within the next 3 years.
Patients who have undergone, or are being actively considered for, liver or kidney transplantation.
Inability to understand and give informed consent to participate.
Adults receiving ongoing routine medical care and regularly using at least 1 (but no more than 6) prescription medications at the time of enrollment.
Cohort
Prospective
Not listed
Feasibility of incorporating pharmacogenomic testing into routine medical care
Find out whether availability of pharmacogenomic information impacts drug decision making in the health care setting
To determine whether access to pharmacogenomic information improves satisfaction with care.
Click on the lead sponsor to view all of their trials.
